These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1316907)

  • 21. Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor.
    Giorgetti S; Pelicci PG; Pelicci G; Van Obberghen E
    Eur J Biochem; 1994 Jul; 223(1):195-202. PubMed ID: 8033892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity.
    Soos MA; Field CE; Lammers R; Ullrich A; Zhang B; Roth RA; Andersen AS; Kjeldsen T; Siddle K
    J Biol Chem; 1992 Jun; 267(18):12955-63. PubMed ID: 1377676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A developmentally regulated form of insulin-like growth factor receptor beta-subunit in C2 myoblasts exhibiting altered requirements for differentiation.
    Barenton B; Domeyne A; Garandel V; Garofalo RS
    Endocrinology; 1993 Aug; 133(2):651-60. PubMed ID: 8344204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between heterologous receptor tyrosine kinases. Hormone-stimulated insulin receptors activate unoccupied IGF-I receptors.
    Tartare S; Ballotti R; Van Obberghen E
    FEBS Lett; 1991 Dec; 295(1-3):219-22. PubMed ID: 1662646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation of tyrosine 992, 1068, and 1086 is required for conformational change of the human epidermal growth factor receptor c-terminal tail.
    Bishayee A; Beguinot L; Bishayee S
    Mol Biol Cell; 1999 Mar; 10(3):525-36. PubMed ID: 10069801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Similar control mechanisms regulate the insulin and type I insulin-like growth factor receptor kinases. Affinity-purified insulin-like growth factor I receptor kinase is activated by tyrosine phosphorylation of its beta subunit.
    Yu KT; Peters MA; Czech MP
    J Biol Chem; 1986 Aug; 261(24):11341-9. PubMed ID: 3015966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity.
    Soos MA; Field CE; Siddle K
    Biochem J; 1993 Mar; 290 ( Pt 2)(Pt 2):419-26. PubMed ID: 8452530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to deduced sequences of the insulin receptor distinguish conserved and nonconserved regions in the IGF-I receptor.
    Herrera R; Petruzzelli LM; Rosen OM
    J Biol Chem; 1986 Feb; 261(6):2489-91. PubMed ID: 3753971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitope mapping of the alpha-chain of the insulin-like growth factor I receptor using antipeptide antibodies.
    Delafontaine P; Ku L; Ververis JJ; Cohen C; Runge MS; Alexander RW
    J Mol Cell Cardiol; 1994 Dec; 26(12):1659-73. PubMed ID: 7731060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of synthetic insulin receptor peptides by the insulin receptor kinase and evidence that the preferred sequence containing Tyr-1150 is phosphorylated in vivo.
    Stadtmauer L; Rosen OM
    J Biol Chem; 1986 Jul; 261(21):10000-5. PubMed ID: 3733682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifunctional glycoprotein receptors for insulin and the insulin-like growth factors.
    Czech MP; Lewis RE; Corvera S
    Ciba Found Symp; 1989; 145():27-41; discussion 42-4. PubMed ID: 2551607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of the C-terminal acidic domain of the insulin receptor with histone modulates the receptor kinase activity.
    Baron V; Kaliman P; Alengrin F; Van Obberghen E
    Eur J Biochem; 1995 Apr; 229(1):27-34. PubMed ID: 7744039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor I-dependent tyrosine kinase activity in stromal cells of human endometrium in vitro.
    Von Eye Corleta H; Strowitzki T; Kellerer M; Häring HU
    Am J Physiol; 1992 Jun; 262(6 Pt 1):E863-8. PubMed ID: 1319680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors.
    Treadway JL; Morrison BD; Soos MA; Siddle K; Olefsky J; Ullrich A; McClain DA; Pessin JE
    Proc Natl Acad Sci U S A; 1991 Jan; 88(1):214-8. PubMed ID: 1846039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single tyrosine substitution in the insulin-like growth factor I receptor inhibits ligand-induced receptor autophosphorylation and internalization, but not mitogenesis.
    Stannard B; Blakesley V; Kato H; Roberts CT; LeRoith D
    Endocrinology; 1995 Nov; 136(11):4918-24. PubMed ID: 7588225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification of insulin-like growth factor I receptor from human placental membranes.
    LeBon TR; Jacobs S; Cuatrecasas P; Kathuria S; Fujita-Yamaguchi Y
    J Biol Chem; 1986 Jun; 261(17):7685-9. PubMed ID: 3011795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-function relationship of the insulin-like growth factor-I receptor tyrosine kinase.
    Grønborg M; Wulff BS; Rasmussen JS; Kjeldsen T; Gammeltoft S
    J Biol Chem; 1993 Nov; 268(31):23435-40. PubMed ID: 7693688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinase inhibition by a phosphorylated peptide corresponding to the major insulin receptor autophosphorylation domain.
    Chavanieu A; Calas B; Vaglio P; Grigorescu F
    Eur J Biochem; 1992 Sep; 208(2):367-73. PubMed ID: 1381676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin-like growth factor-mediated phosphorylation and protooncogene induction in Madin-Darby canine kidney cells.
    Hauguel-de Mouzon S; Kahn CR
    Mol Endocrinol; 1991 Jan; 5(1):51-60. PubMed ID: 1708099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An antipeptide antibody that specifically inhibits insulin receptor autophosphorylation and protein kinase activity.
    Herrera R; Petruzzelli L; Thomas N; Bramson HN; Kaiser ET; Rosen OM
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):7899-903. PubMed ID: 2415975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.